Stock data
Ocular Therapeutix, Inc. (OCUL)
Ocular Therapeutix, Inc. (OCUL) reported revenue of US$51.95M and net income of -US$265.94M for fiscal 2025. The figures below come from the company's SEC filings.
Annual results
Data as of 2025-12-31
| Fiscal year | Revenue | Gross profit | Operating income | Net income | Diluted EPS |
|---|---|---|---|---|---|
| 2025 | US$51.95M | — | -US$270.02M | -US$265.94M | — |
| 2024 | US$63.72M | — | -US$171.78M | -US$193.51M | — |
| 2023 | US$58.44M | — | -US$82.38M | -US$80.74M | — |
| 2022 | US$51.49M | — | -US$78.65M | -US$71.04M | — |
| 2021 | US$43.52M | — | -US$78.04M | -US$6.55M | — |
Quarterly results
Data as of 2026-06-30
| Quarter | Revenue | Net income | Diluted EPS |
|---|---|---|---|
| 2026-06-30 | US$13.47M | -US$78.76M | — |
| 2026-03-31 | US$10.79M | -US$88.61M | — |
| 2025-12-31 | US$13.25M | -US$64.65M | — |
| 2025-09-30 | US$14.54M | -US$69.42M | — |
| 2025-06-30 | US$13.46M | -US$67.81M | — |
| 2025-03-31 | US$10.70M | -US$64.05M | — |
| 2024-12-31 | US$17.08M | -US$48.39M | — |
| 2024-09-30 | US$15.43M | -US$36.49M | — |
Sources
- Source: SEC EDGAR company facts
Charts, drawing tools, and the P/E calculator are in the app, free to use.